Organizing pneumonia in a patient with rheumatoid arthritis treated with etanercept

Mod Rheumatol. 2010 Dec;20(6):611-6. doi: 10.1007/s10165-010-0327-1. Epub 2010 Jun 24.

Abstract

Etanercept-induced organizing pneumonia (OP) has not been reported in Japan. We describe the case of a rheumatoid arthritis patient who developed OP during etanercept treatment and discuss the possible mechanisms underlying the development of etanercept-induced OP and the existence of factors that predispose Japanese patients to drug-induced OP.

Publication types

  • Case Reports

MeSH terms

  • Antirheumatic Agents / adverse effects*
  • Arthritis, Rheumatoid / complications
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / pathology
  • Cryptogenic Organizing Pneumonia / chemically induced*
  • Cryptogenic Organizing Pneumonia / drug therapy
  • Cryptogenic Organizing Pneumonia / pathology
  • Cysteine / analogs & derivatives
  • Cysteine / therapeutic use
  • Drug Therapy, Combination
  • Etanercept
  • Female
  • Humans
  • Immunoglobulin G / adverse effects*
  • Methotrexate / therapeutic use
  • Middle Aged
  • Radiography, Thoracic
  • Receptors, Tumor Necrosis Factor
  • Treatment Outcome

Substances

  • Antirheumatic Agents
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Cysteine
  • Etanercept
  • bucillamine
  • Methotrexate